15 MAY 2018 2Q 2018 PERFORMANCE 2Q 2018 P&L SNAPSHOT AND ANALYSIS (THB mn) 2Q 2018 2Q 2017 YoY 1Q 2018 % QoQ Operating revenues 1,642.9 665.4 146.9% 1,335.4 23.0% Other revenues 148.1 82.5 79.5% 146.1
Summary Significant Event & Business Overview Operating Highlights in Q3/2024 Q3/23 Q3/24 Change +/(-) 9M/23 9M/24 Change +/(-) (THB million) %YoY %YoY Operating Revenue 338 428 27% 900 1,144 27% Gross
such as India, Russia and ASEAN for instance. And additionally, the Company must be temporary closed from 19 March 2020. (million) 2020 2019 increase (decrease) million % Sale of tickets 164.06 289.88
crowded places, asked for people cooperation to work from home and imposed the curfew from 10 p.m. to 4 a.m. starting from April 3, 2020 in order to limit the movement of people, which led to the decrease
)% Net fees and service income to operating income ratio 22.7% 21.2% 21.2% 1.5% 1.5% 22.6% 22.2% 0.4% Non-interest income in the third quarter of 2019 was Baht 12,295 million, a decrease of Baht 1,239
: Operating Performance Results - Q3/2017 (vs Q3/2016) (Baht – Million) Q3/2017 Q3/2016 Changes YoY (Increase + / Decrease -) Amount % Amount % Amount % Hotels Business Revenues 2,093.9 43.1% 2,096.0 44.4% -2.1
decrease in gross profit of VSPP and Others. 71% 26% 3% PAGE 3 MANAGEMENT DISCUSSION & ANALYSIS (MD&A) Q1 2019 Executive Summary Q1/2019 Significant Events Dividend Payment from GPSC’s Operating Result for
-1- AIT (VP-SEC) 003E/2024 15 February 2024 Subject: Management's Discussion and Analysis of Operating Results for the year 2023 and Q4-2023 To: The President of the Stock Exchange of Thailand
same period of last year in the same trend of its industries. Cost of Goods Sold In Q1.2018, the Company and its subsidiaries had cost of goods sold (COGS) THB 894.7 mn represents a decrease of COGS to
. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public